Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Memo Reiterates Off-Label Enforcement Policy

Jan 24 2017

• By Brenda Sandburg

Related Content

FDA Cracks Open Door For More Manufacturer Communications

Jan 20 2017

US FDA Clarifies ‘Intended Use’ Policy For Approved Products

Jan 17 2017

Vascular Solutions Case (Partially) Points Way Forward For Off-Label Marketing

Apr 06 2016

US FDA Hears Competing Messages On Off-Label Communications

Nov 11 2016

Related Companies

Amarin Corp plc

Pfizer Inc.

Additional Topics

United States Advertising, Marketing & Sales Regulation FDA Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window